EU Regulatory Roundup, August 2018: More Push For Reg Delays; Brexit Planning Raises Questions
Device companies, under increasing time pressures, gained the support of some EU member state ministers to lengthen transitions for the new regulations. Also, the UK disclosed more about what could happen in the event of a no-deal Brexit. That, and more, in Medtech Insight's August top 10 articles covering EU regulations.
You may also be interested in...
The US agency sent a letter to health-care providers spotlighting its analysis of the increasing numbers of adverse events linked to surgical staplers and implantable staples, and its plans for a draft guidance on labeling and an advisory panel meeting to consider a 510(k) requirement for the products.
On the latest Medtech Insight podcast, David Filmore and Ferdous Al-Faruque discuss the unexpected news that Scott Gottlieb is leaving US FDA next month. What has been his legacy for medtech, and who will replace him?
The commissioner says he will step down next month, leaving a legacy of active policy development, but also a lot of initiatives and pilot projects that are in the middle of being implemented.